Yaakov Dickstein
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 21
-
- Antibiotic Use and Resistance 12
- Co-authors
- Mical Paul (12 shared papers)Leonard Leibovici (5 shared papers)Ayelet Raz‐Pasteur (1 shared paper)Ami Neuberger (4 shared papers)Karla Soares‐Weiser (1 shared paper)Simona Grozinsky‐Glasberg (1 shared paper)Agata Schlesinger (1 shared paper)Dafna Yahav (4 shared papers)
In The Last Decade
Yaakov Dickstein
41 papers receiving 1.9k citations
Yaakov Dickstein's Hit Papers
Peers
Comparison fields: 5 of 84
- Applied Microbiology and Biotechnology 389
- Molecular Medicine 915
- Pharmacology 240
- Critical Care and Intensive Care Medicine 67
- Clinical Biochemistry 61
Countries citing papers authored by Yaakov Dickstein
This map shows the geographic impact of Yaakov Dickstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaakov Dickstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaakov Dickstein more than expected).
Fields of papers citing papers by Yaakov Dickstein
This network shows the impact of papers produced by Yaakov Dickstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaakov Dickstein. The network helps show where Yaakov Dickstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaakov Dickstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial Hit paper breakdown → | 2018 | 513 |
| 2 | Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial Hit paper breakdown → | 2018 | 339 |
| 3 | 2015 | 120 | |
| 4 | 2013 | 108 | |
| 5 | 2018 | 102 | |
| 6 | 2016 | 82 | |
| 7 | 2016 | 74 | |
| 8 | 2016 | 69 | |
| 9 | 2020 | 64 | |
| 10 | 2019 | 47 | |
| 11 | 2016 | 45 | |
| 12 | 2016 | 39 | |
| 13 | 2017 | 37 | |
| 14 | 2018 | 37 | |
| 15 | 2019 | 30 | |
| 16 | 2021 | 27 | |
| 17 | 2016 | 25 | |
| 18 | 2023 | 24 | |
| 19 | 2014 | 18 | |
| 20 | 2019 | 17 |
About Yaakov Dickstein
Yaakov Dickstein is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Epidemiology and Critical Care and Intensive Care Medicine, having authored 41 papers that have together received 2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (21 papers), Antibiotic Use and Resistance (12 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Sepsis Diagnosis and Treatment (3 papers), Bacterial Identification and Susceptibility Testing (2 papers), Bacterial biofilms and quorum sensing (2 papers), Urinary Tract Infections Management (2 papers) and Ethics in Clinical Research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (389 citations), Molecular Medicine (915 citations), Pharmacology (240 citations), Critical Care and Intensive Care Medicine (67 citations) and Clinical Biochemistry (61 citations). Yaakov Dickstein has collaborated with scholars based in Israel, Italy and Greece. Frequent co-authors include Mical Paul, Leonard Leibovici, Ayelet Raz‐Pasteur, Ami Neuberger, Karla Soares‐Weiser, Simona Grozinsky‐Glasberg, Agata Schlesinger, Dafna Yahav, Khetam Hussein and Tali W. Dror. Their work appears in journals such as Clinical Microbiology and Infection, Clinical Infectious Diseases, Antimicrobial Resistance and Infection Control, Cochrane Database of Systematic Reviews and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.